“…These adaptations evolved by maintaining lowered steady-state levels of mTORC1 content or activity [ 14 , 25 , 26 , 33 , 34 ], reducing the content of mTORC1 upstream regulators [ 14 , 25 , 26 , 28 ], or lowering the activation of its downstream effectors [ 14 , 22 , 23 , 25 , 29 , 30 ]. Furthermore, these regulations operate at all expression levels, either genes [ 14 , 25 , 26 ], proteins [ 14 , 22 , 23 ], or metabolites [ 14 ]. Apart from the metabolic effects resulting from a reduced pathway activity, reduced mTORC1 is essential to maintaining its integrity [ 35 ].…”